GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanobiotix SA (LTS:0QAV) » Definitions » Cash Flow for Dividends

Nanobiotix (LTS:0QAV) Cash Flow for Dividends : €0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Nanobiotix Cash Flow for Dividends?

Nanobiotix's cash flow for dividends for the six months ended in Jun. 2024 was €0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Nanobiotix Cash Flow for Dividends Historical Data

The historical data trend for Nanobiotix's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanobiotix Cash Flow for Dividends Chart

Nanobiotix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Nanobiotix Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nanobiotix Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanobiotix Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Nanobiotix's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanobiotix Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanobiotix SA (LTS:0QAV) » Definitions » Cash Flow for Dividends
Comparable Companies
XPAR:DBV XPAR:IPH XPAR:IVA XPAR:AELIS XPAR:MEDCL XPAR:GNFT XPAR:TNG XPAR:ALSEN XPAR:ADOC XPAR:OSE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
NBTX:USA NANO:France 5NRA:Germany
Address
60 Rue de Wattignies, Paris, FRA, 75012
Website
https://www.nanobiotix.com
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Nanobiotix Headlines

No Headlines